http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007107664-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_893c65e4861197b96bb03ddc579a553c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68f2bd3d611c7a2a832128d8430d9193
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406
filingDate 2007-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_496df50a0402db7e3c88e17adfd73766
publicationDate 2008-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007107664-A3
titleOfInvention Use of e-3-[3-[n-(4-methoxybenzenesulfonyl)-n-isopropylamino]phenyl]-3-(3-pyridyl)propenohydroxamic acid for preparing a medicament for preventing and/or treating inflammatory skin pathologies
abstract The invention relates to the use of E-3-[3-[N-(4-methoxybenzenesulfonyl)-N-isopropylamino]phenyl]-3-(3-pyridyl)propenohydroxamic acid of formula (I), or a pharmaceutically acceptable salt, pharmaceutically acceptable solvate or hydrate thereof, for preparing a medicament for preventing and/or treating inflammatory skin pathologies. The invention also relates to pharmaceutical, especially dermatological, compositions, comprising E-3-[3-[N-(4-methoxybenzenesulfonyl)-N-isopropylamino]phenyl]-3-(3-pyridyl)propenohydroxamic acid, or a pharmaceutically acceptable salt, pharmaceutically acceptable solvate, or hydrate thereof, for treating and/or preventing inflammatory skin pathologies.
priorityDate 2006-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004122011-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1314721-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9869199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87638986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230184959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229508867

Total number of triples: 20.